Hepatic and renal extraction of circulating type I procollagen aminopropeptide in patients with normal liver function and in patients with alcoholic cirrhosis

被引:2
|
作者
Schytte, S
Hansen, M
Moller, S
Junker, P
Henriksen, JH
Hillingso, J
Teisner, B
机构
[1] Odense Univ Hosp, Dept Internal Med C, Odense, Denmark
[2] Hvidovre Univ Hosp, Dept Rheumatol, Connect Tissue Lab, Copenhagen, Denmark
[3] Univ Copenhagen, Hvidovre Hosp, Dept Clin Physiol, Copenhagen, Denmark
[4] Hvidovre Univ Hosp, Dept Gastroenterol, Copenhagen, Denmark
[5] Odense Univ, Dept Med Microbiol, Odense, Denmark
关键词
aminoterminal propeptide of type I procollagen; clearance; collagen; ELISA; liver cirrhosis; procollagen; size-chromatography;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The circulating level and splanchnic and renal extraction of serum type I procollagen aminoterminal propeptide (PINP) was studied in 20 patients with normal liver function and in 15 patients with alcoholic liver cirrhosis. In patients with alcoholic cirrhosis, the concentration of PINP in the femoral artery blood was significantly higher than in the group of patients with normal liver function (median 145 mu g/l, 95% CI 98-195 versus 57 mu g/l, 95% CI 42-92, p < 0.001). A significant decrease in the concentration of PINP between the femoral artery (median 57 mu g/l, 95% CI 42-92) and the hepatic vein (median 45 mu g/l, 95% CI 40-70, p < 0.001) was found in patients with normal liver function. rn this group we also observed a significantly higher concentration of PINP in femoral artery blood (median 60 mu g/l, 95% CI 45-87) as compared with that in renal vein (median 50 mu g/l, 95% CI 40-65, p < 0.001). In contrast, serum-PINP did not differ between arterial and hepatic or venous venous blood in patients with alcoholic cirrhosis. Size-chromatography revealed no significant change in the ratio of the high and low molecular forms of PINP following extraction in liver and kidney. It is concluded that circulating PINP is extracted in the normal liver and kidney, and that the serum concentration of PINP is significantly higher in patients with alcoholic cirrhosis than in patients with normal liver function. Both the hepatic and the renal clearance of PINP are seriously impaired/reduced in patients with alcoholic cirrhosis.
引用
收藏
页码:627 / 633
页数:7
相关论文
共 36 条
  • [21] RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM ASSOCIATED WITH THE TYPE-I COLLAGEN GENE IN JAPANESE PATIENTS WITH ALCOHOLIC LIVER-CIRRHOSIS
    OHATA, M
    YAMAUCHI, M
    TODA, G
    INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 1994, 2 (01): : 14 - 20
  • [22] CIRCULATING VASCULAR ENDOTHELIAL GROWTH FACTOR AND NITRIC OXIDE IN PATIENTS WITH LIVER CIRRHOSIS: A POSSIBLE ASSOCIATION WITH LIVER FUNCTION IMPAIRMENT
    Abdelmoaty, Mohamed Ahmed
    Bogdady, Ahmed Mohamed
    Attia, Mervat Mohamed
    Zaky, Nayel Abdelhamed
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2009, 24 (04) : 398 - 403
  • [23] Circulating vascular endothelial growth factor and nitric oxide in patients with liver cirrhosis: A possible association with liver function impairment
    Mohamed Ahmed Abdelmoaty
    Ahmed Mohamed Bogdady
    Mervat Mohamed Attia
    Nayel Abdelhamed Zaky
    Indian Journal of Clinical Biochemistry, 2009, 24 (4) : 398 - 403
  • [24] CLIF-SOFA score and SIRS are independent prognostic factors in patients with hepatic encephalopathy due to alcoholic liver cirrhosis
    Jeong, Jin Hee
    Park, In Sung
    Kim, Dong Hoon
    Kim, Seong Chun
    Kang, Changwoo
    Lee, Soo Hoon
    Kim, Tae Yun
    Lee, Sang Bong
    MEDICINE, 2016, 95 (26)
  • [25] Type I interferon signaling in systemic immune cells from patients with alcoholic cirrhosis and its association with outcome
    Weiss, Emmanuel
    Rautou, Pierre-Emmanuel
    Fasseu, Magali
    Giabicani, Mikhael
    de Chambrun, Marc
    Wan, JingHong
    Minsart, Charlotte
    Gustot, Thierry
    Couvineau, Alain
    Maiwall, Rakhi
    Hurtado-Nedelec, Margarita
    Pilard, Nathalie
    Lebrec, Didier
    Valla, Dominique
    Durand, Francois
    de la Grange, Pierre
    Monteiro, Renato C.
    Paugam-Burtz, Catherine
    Lotersztajn, Sophie
    Moreau, Richard
    JOURNAL OF HEPATOLOGY, 2017, 66 (05) : 930 - 941
  • [26] THE RELATIONSHIP BETWEEN PHARMACOKINETIC BEHAVIOR OF GLYCYRRHIZIN AND HEPATIC-FUNCTION IN PATIENTS WITH ACUTE HEPATITIS AND LIVER-CIRRHOSIS
    YAMAMURA, Y
    TANAKA, N
    SANTA, T
    KOTAKI, H
    AIKAWA, T
    UCHINO, K
    OSUGA, T
    SAWADA, Y
    IGA, T
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1995, 16 (01) : 13 - 21
  • [27] Clinical Characteristics, Treatment Effects and Risk Factors of Liver Cirrhosis in Patients with Wilson's Disease Hepatic Type
    Lu, Yu-Jia
    Yuan, Chuan-Su
    Ma, Yue-Yang
    Ou, Ke-Ying
    Liu, Du-Xian
    Liu, Bin
    Yang, Yong-Feng
    Xiong, Qing-Fang
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2025, : 306 - 314
  • [28] Liver Cirrhosis Patients Who Had Normal Liver Function Before Liver Cirrhosis Development Have the Altered Metabolic Profiles Before the Disease Occurrence Compared to Healthy Controls
    Yoo, Hye Jin
    Jung, Keum Ji
    Kim, Minkyung
    Kim, Minjoo
    Kang, Minsik
    Jee, Sun Ha
    Choi, Yoonjeong
    Lee, Jong Ho
    FRONTIERS IN PHYSIOLOGY, 2019, 10
  • [29] A multicenter, phase I, pharmacokinetic study of osimertinib in cancer patients with normal renal function or severe renal impairment
    Vishwanathan, Karthick
    Sanchez-Simon, Inmaculada
    Keam, Bhumsuk
    Penel, Nicolas
    Miguel-Luken, Maria
    Weilert, Doris
    Mills, Andrew
    Marotti, Marcelo
    Johnson, Martin
    Ravaud, Alain
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2020, 8 (04):
  • [30] Evaluation of balloon-occluded hepatic venography with carbon dioxide for portography and correlation between retrograde portogram and liver function in patients with liver cirrhosis
    Ishikawa, A
    Nishida, H
    Baba, T
    Mitamura, K
    HEPATOLOGY RESEARCH, 2000, 18 (03) : 239 - 251